UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000005569
Receipt No. R000005889
Scientific Title Phase II study of maintenance Bevacizumab with Pemetrexed after induction therapy of Cisplatin, Pemetrexed, and Bevacizumab in patients with advanced non-squamous non-small-cell lung cancer
Date of disclosure of the study information 2011/05/08
Last modified on 2019/07/29 11:58:25

No. Disposal Last modified on Item of update
1 Insert 2011/05/08 09:56:52
2 Update 2014/01/10 12:18:57 Email
Address
Address
TEL
Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2017/04/04 16:28:59 Control
4 Update 2017/04/04 16:29:55 Name of primary sponsor
Institute
Organization
Organization
5 Update 2017/04/04 16:30:15 Recruitment status
6 Update 2019/07/29 11:21:27 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address
Address
TEL

Last name of contact person

Last name of contact person
Zip code
Address
Address
TEL
Organization
Organization
Organization
Address
Address
Tel
Email
7 Update 2019/07/29 11:51:30 Recruitment status
Date of IRB
Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
8 Update 2019/07/29 11:53:38 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
9 Update 2019/07/29 11:58:25 URL related to results and publications


Contact us.